Inaugural Guidelines for Patients With HIV Aim to Expand Therapy Options

Wayne Kuznar
Published: Saturday, May 12, 2018
Gita Suneja, MD

Gita Suneja, MD
The HIV status of a patient who is living with the infection and has been diagnosed with cancer may be a component of a diagnostic workup but should not be the sole determining factor in making decisions about treatment, according to the first set of National Comprehensive Cancer Network (NCCN) guidelines for this population.1

A consult with both an oncologist and an HIV pharmacist before initiating cancer therapy is recommended because of the possibility of drug– drug interactions, and co-management is critical. Suneja also noted that testing for CD4 T-cell count and viral load should be done more frequently to prevent potential interactions that could make ART less effective.

Non-AIDS-Defining Cancer

Kaposi Sarcoma
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Therapies for Patients With ALK-Positive Lung Cancers: More Options…More Decisions…Better OutcomesAug 30, 20191.5
Oncology Briefings™: Treating Advanced NSCLC Without Actionable MutationsAug 30, 20191.0
Publication Bottom Border
Border Publication
x